SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

DCM Shriram moves up on getting nod to make further investment in its subsidiary

19 Aug 2022 Evaluate

DCM Shriram is currently trading at Rs. 1045.45, up by 13.20 points or 1.28% from its previous closing of Rs. 1032.25 on the BSE.

The scrip opened at Rs. 1049.40 and has touched a high and low of Rs. 1057.05 and Rs. 1032.20 respectively. So far 304 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 1263.85 on 28-Apr-2022 and a 52 week low of Rs. 855.50 on 24-Aug-2021.

Last one week high and low of the scrip stood at Rs. 1075.00 and Rs. 1011.35 respectively. The current market cap of the company is Rs. 16302.99 crore.

The promoters holding in the company stood at 66.52%, while Institutions and Non-Institutions held 11.84% and 21.64% respectively.

DCM Shriram has received approval to make the further investment of upto Rs 70 crore in subsidiary company -- DCM Shriram Bio EnChem by way of capital investments in one or more form of securities in one or more tranches. The company has also received approval to carry out the manufacture Sulphate of Potash (K2SO4) project through its subsidiary company -- DCM Shriram Bio EnChem. The Board of directors of the company at its meeting held on August 18, 2022 has approved the same.

DCM Shriram is engaged in the business of fertilizer, sugar and caustic soda.


DCM Shriram Share Price

1225.85 40.85 (3.45%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Grasim Industries 2718.25
DCM Shriram 1225.85
3M India 31394.15
Hindustan Foods 509.15
Balmer Lawrie & Co 176.20
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×